×

Illumina CEO: On the path to $100 genome

8:39 AM ET Tue, 10 Jan 2017

CNBC's Meg Tirrell talks to Illumina CEO Francis deSouza about lowering the price of genome sequencing and the opportunity it opens up for advancements in medical research.